Che-Ming Teng
41Patents
8h-index
92Co-inventors
78Inventor score
Filing activity: Jan 28, 1991 → Mar 20, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7166293B2 | Angiogenesis inhibitors | Human Necessities | 107 | Expired |
| US6635649B2 | Piperazinedione compounds | Chemistry; Metallurgy | 41 | Expired |
| US7288545B2 | Piperazinedione compounds | Chemistry; Metallurgy | 37 | Expired |
| US6274177A | Method of preparing an extract potent in anti-inflammation and anti-platelet aggregation from Zingiber officinale and pharmaceutical compositions containing said extract | Human Necessities | 19 | Expired |
| US5574168A | 1-(substituted benzyl)-3-(substituted aryl)-condensed pyrazole derivatives and processes of making the same | Chemistry; Metallurgy | 12 | Expired |
| US7514465B2 | Synthesis of N2-(substituted arylmethyl)-3-(substituted phenyl)indazoles as novel anti-angiogenic agents | Chemistry; Metallurgy | 12 | Active |
| US6518294B2 | Fused pyrazolyl compounds | Human Necessities | 9 | Expired |
| US5646164A | .alpha.-methylene-.gamma.-butyrolactones: new inhibitors of platelet aggregation | Chemistry; Metallurgy | 9 | Expired |
| US5137912A | Chelerythrine inhibits platelet aggregation--a potential anti-aggregation drug | Human Necessities | 5 | Expired |
| US6897316B2 | Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents | Human Necessities | 5 | Expired |
| US6387942B2 | Method of treating disorders related to protease-activated receptors-induced cell activation | Chemistry; Metallurgy | 5 | Expired |
| US5495005A | Synthesis and pharmacological activity of a series of novel xanthone derivatives | Chemistry; Metallurgy | 2 | Expired |
| US8846748B2 | Indolyl or indolinyl hydroxamate compounds | Chemistry; Metallurgy | 2 | Active |
| US7378532B2 | Fused pyrazolyl compound | Chemistry; Metallurgy | 2 | Expired |
| US5853731A | Thromboxane A2 Receptor antagonism and antioxidant action of cinnamophilin and its derivatives, their pharmaceutical compositions and uses | Chemistry; Metallurgy | 2 | Expired |
| US7049334B2 | Enhancement of learning and memory and treatment of amnesia | Human Necessities | 2 | Expired |
| US5262421A | Use of dicentrine and its derivatives for the treatment of hypertension, arrhythmia, thrombosis and atherosclerosis | Human Necessities | 2 | Expired |
| US8440692B2 | Hydrophilic derivatives of 2-aryl-4-quinolones as anticancer agents | Chemistry; Metallurgy | 2 | Active |
| US5563167A | Abruquinone derivatives and their uses | Chemistry; Metallurgy | 1 | Expired |
| US6943186B2 | Methods of treating sepsis | Chemistry; Metallurgy | 1 | Expired |
| US5594033A | Secoaporphine compound on arrhythmia | Chemistry; Metallurgy | 1 | Expired |
| US5240947A | 2,3,4,5-substituted furo[2,3-c]pyrazole derivatives | Chemistry; Metallurgy | 1 | Expired |
| US8501957B2 | Benzimidazole compounds and their use as anticancer agents | Chemistry; Metallurgy | 1 | Active |
| US9216977B2 | Antofine and cryptopleurine derivatives as anticancer agents | Chemistry; Metallurgy | 1 | Active |
| US11278523B2 | Indoline derivatives for treatment and/or prevention of fibrosis diseases | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.